Syndax Pharmaceuticals ( NASDAQ:SNDX – Get Rating ) had its target price hoisted by HC Wainwright from $33.00 to $36.00 in a research note released on Tuesday morning, The Fly reports. HC Wainwright also issued estimates for Syndax Pharmaceuticals' Q2 2023 earnings at ($0.70) EPS, Q3 2023 earnings at ($0.83) EPS, Q3 2023 earnings at ($0.83) EPS, Q4 2023 earnings at ($1.00) EPS, FY2023 earnings at ($3.12) EPS, FY2024 earnings at ($2.23) EPS and FY2025 earnings at ($2.15) EPS. Several other brokerages also recently commented on SNDX.

https://www.dailypolitical.com/2023/05/12/syndax-pharmaceuticals-nasdaqsndx-given-new-36-00-price-target-at-hc-wainwright.html

#dailypolitical